San Carlos, CA, United States of America

Gerald Zon

This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Nucleic Acid Chemistry. Top assignees: Applied Biosystems, LLC, Applera Corporation, Trilink Biotechnologies, Inc.. Active years: 1991-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald Zon. Retrieved from https://idiyas.com/inventor/gerald-zon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 6)

% Patents Active = 57.9

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 471(Granted Patents)

Company Filing History:

8 out of 532

Applied Biosystems, LLC

Trilink Biotechnologies, Inc.

patents

4. 2 out of 1,896

Life Technologies Corporation

patents

5. 2 out of 801

The Perkin-Elmer Corporation

patents

Years Active: 1991-2017

Loading Chart...

Areas of Expertise:

Ligase Cofactors

Nucleotide Sequencing

Oligonucleotide Primers

Nucleic Acid Amplification

5-Methylcytosine Detection

Bisulfite Conversion

Polynucleotide Synthesis

Thiohydantoins

Automated Systems

Catalyzed Reactions

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9631227 - Chemically modified ligase cofactors, donors and acceptors (2017-04-25),

2. 8728725 - Chemically modified ligase cofactors, donors and acceptors (2014-05-20),

3. 8715938 - Reversible di-nucleotide terminator sequencing (2014-05-06),

4. 8361753 - Phosphotriester-modified oligonucleotide primers for nucleic acid amplification (2013-01-29),

5. 8017338 - Reversible di-nucleotide terminator sequencing (2011-09-13),

6. 7999091 - 5-methylcytosine detection, compositions and methods therefor (2011-08-16),

7. 7824887 - Reversible terminator nucleotides and methods of use (2010-11-02),

8. 7553949 - Reversible terminator nucleotides and methods of use (2009-06-30),

9. 7534873 - Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil (2009-05-19),

10. 7399614 - 5-methylcytosine detection, compositions and methods therefor (2008-07-15),

11. 7371526 - Method and materials for bisulfite conversion of cytosine to uracil (2008-05-13),

12. 7368239 - Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil (2008-05-06),

13. 7262013 - Bisulfite method (2007-08-28),

14. 6175006 - Automated system for polynucleotide synthesis and purification (2001-01-16),

15. 5935527 - Automated system for polynucleotide synthesis and purification (1999-08-10),

Title: The Innovative Journey of Gerald Zon

Introduction: Gerald Zon, a talented inventor based in San Carlos, CA (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Gerald Zon holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Gerald Zon has worked for leading tech companies, where he spearheaded research and development projects that have resulted in cutting-edge innovations. His expertise in patent law has also enabled him to protect his inventions effectively.

Collaborations: Throughout his career, Gerald Zon has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: Gerald Zon's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.